CLDN6 CAR-T

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

73 competitors in Effectiveness

#DrugCompanyPhaseTrials

1

Kesimpta

Novartis

Phase 3

22

Mounjaro

Eli Lilly

Phase 3

13

Actos

Takeda

Phase 3

14

Nicotine Free Cigarettes

Pfizer

Phase 3

35

Botulinum Toxin a

GSK

Phase 3

16

Gemzar

Johnson & Johnson

Phase 2

17

Droxia

TTheravia

Phase 2

98

Haldol

DDePuy Orthopaedics

Phase 2

19

Temodar

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Phase 2

110

Pneumococcal Conjugate Vaccine

Novartis

Phase 3

1Show 28 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Effectiveness1 trial

A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors

Recruiting·BBioNTech Cell & Gene Therapies GmbH·Phase 1·NCT04503278·214 enrolled

Testicular Cancer1 trial

A Clinical Study Investigating the Therapeutic Effects and Safety of an Investigational Cell Therapy Given With and Without an Additional Investigational Product in Males With Testicular Cancer or a Form of Cancer That Developed From Sperm

Withdrawn·BioNTech·Phase 2·NCT06940804

Details

Drug Info

Related News